first large study of glp 1 receptor agonists during pregnancy New developments in GLP-1 agonist therapy for gestational diabetes: Systematic review on liraglutide, semaglutide, and exenatide from ClinicalTrials.gov Continuing Glucagon-Like Peptide-1 Receptor

first large study of glp 1 receptor agonists during pregnancy New developments in GLP-1 agonist therapy for gestational diabetes: Systematic review on liraglutide, semaglutide, and exenatide from ClinicalTrials.gov Continuing Glucagon-Like Peptide-1 Receptor

Continuing Glucagon-Like Peptide-1 Receptor Agonists Into the First Trimester of Pregnancy and Pregnancy Outcomes: A Target Trial Emulation Study Using Claims Information: Annals of Internal Medicine: Vol 179, No 7

We changed pharmacy vendor, now you can’t get it unless you have had a history of diabetes.” – Senior Benefits Manager, large manufacturer “We’ve never offered it for weight loss, and it is still one of our top three prescriptions spends every year.” – HR Professional, large manufacturer “We don’t allow GLP-1s for weight loss… In our type 2 diabetes population, 50% are utilizing the GLP-1s, so we are now excluding them for anything except type 2 diabetes [to manage costs].” – Director of Benefits, large manufacturer The future of GLP-1 drug prices Employers are also recognizing that the price paid by employers for GLP-1 drugs are sometimes higher than online direct-to-consumer prices reflecting manufacturer discounts

You may have to jump through more hoops to get your prescription covered